$GRDI
Stock $grdi

$grdi Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000156459023004568 Filed on March 28, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue	$3.340M		$12.23M
YoY Change			142.05%
Gross Profit	$1.118M		$10.12M
YoY Change			-60.72%
Gross Profit Margin
Selling, General & Admin	$3.808M		$20.60M
YoY Change			80.27%
% of Gross Profit	340.61%		203.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.571M		$7.128M
YoY Change			113.73%
% of Gross Profit	140.52%		70.42%
Operating Expenses	$933.0K	$1.432M	$2.941M
YoY Change	54.95%	-52.73%	-20.6%
Operating Profit	-$933.0K		-$2.941M
YoY Change	54.95%		-20.6%
Interest Expense	$1.951K	$2.241M	$3.984M
YoY Change	-97.31%	6905.25%	3351.22%
% of Operating Profit
Other Income/Expense, Net	$46.79K	-$123.5K	$8.569M
YoY Change	-97.43%	-112.92%	699.76%
Pretax Income	-$886.2K	$686.0K	$5.628M
YoY Change	-172.77%	-133.62%	-313.77%
Income Tax	$35.56K	$478.5K	$795.2K
% Of Pretax Income		69.76%	14.13%
Net Earnings	-$921.8K	$207.5K	$4.833M
YoY Change	-175.69%	-110.17%	-283.57%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.10		$0.14
Diluted Earnings Per Share	-$0.10	$0.02	$0.14
COMMON SHARES
Basic Shares Outstanding	9.367M	34.50M	6.900M
Diluted Shares Outstanding	6.900M		6.900M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$246.7K	$992.2K	$992.2K
YoY Change	-0.39%	114.63%	114.63%
Cash & Equivalents	$246.7K	$992.2K
Short-Term Investments
Other Short-Term Assets	$94.97K	$1.171M	$1.171M
YoY Change	-55.24%	341.41%	341.41%
Inventory
Prepaid Expenses	$94.97K	$77.77K
Receivables
Other Receivables		$295.0K
Total Short-Term Assets	$1.082M	$2.163M	$2.163M
YoY Change	135.23%	197.32%	197.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$37.79M	$37.16M	$39.71M
YoY Change			75.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$4.941M
YoY Change			-53.03%
Other Assets	$25.69M	$25.04M	$25.04M
YoY Change	-90.69%	-90.93%	-90.93%
Total Long-Term Assets	$25.69M	$25.04M	$25.04M
YoY Change	-90.69%	-90.93%	-90.93%
TOTAL ASSETS
Total Short-Term Assets	$1.082M	$2.163M	$2.163M
Total Long-Term Assets	$25.69M	$25.04M	$25.04M
Total Assets	$26.77M	$27.20M	$27.20M
YoY Change	-90.32%	-90.17%	-90.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.876M	$4.598M	$4.598M
YoY Change			312.38%
Accrued Expenses	$5.966M	$4.807M	$4.807M
YoY Change	81.72%	52.43%	52.43%
Deferred Revenue
YoY Change
Short-Term Debt	$502.7K	$1.393M	$1.393M
YoY Change	235.12%	828.8%	828.8%
Long-Term Debt Due	$446.1K		$1.044M
YoY Change
Total Short-Term Liabilities	$7.468M	$7.135M	$7.135M
YoY Change	114.49%	114.73%	114.73%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$7.373M	$7.221M	$7.221M
YoY Change	-43.1%	-50.89%	-50.89%
Total Long-Term Liabilities	$7.373M	$7.221M	$7.221M
YoY Change	-43.1%	-50.89%	-50.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.468M	$7.135M	$7.135M
Total Long-Term Liabilities	$7.373M	$7.221M	$7.221M
Total Liabilities	$14.84M	$14.36M	$14.36M
YoY Change	-9.72%	-20.36%	-20.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.45M	-$13.53M
YoY Change	-9.42%	-21.21%
Common Stock	$523.9K	$1.104M
YoY Change	75821.88%	159859.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$13.93M	-$12.43M	$12.85M
YoY Change
Total Liabilities & Shareholders Equity	$26.77M	$27.20M	$27.20M
YoY Change	-90.32%	-90.17%	-90.17%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$921.8K	$207.5K	$4.833M
YoY Change	-175.69%	-110.17%	-283.57%
Depreciation, Depletion And Amortization	$1.571M		$7.128M
YoY Change			113.73%
Cash From Operating Activities	-$948.1K	-$234.2K	-$965.7K
YoY Change	152.44%	218.49%	43.64%
INVESTING ACTIVITIES
Capital Expenditures	$23.00K		$14.11M
YoY Change			-43.07%
Acquisitions
YoY Change
Other Investing Activities	-$444.1K	$254.9M	$255.1M
YoY Change	-375.86%		-192.41%
Cash From Investing Activities	-$444.1K	$254.9M	$255.1M
YoY Change	-375.86%		-192.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	646.8K	-253.7M	-253.6M
YoY Change			-191.51%
NET CHANGE
Cash From Operating Activities	-948.1K	-234.2K	-965.7K
Cash From Investing Activities	-444.1K	254.9M	255.1M
Cash From Financing Activities	646.8K	-253.7M	-253.6M
Net Change In Cash	-745.5K	961.3K	529.9K
YoY Change	247.4%	-1407.06%	24.2%
FREE CASH FLOW
Cash From Operating Activities	-$948.1K	-$234.2K	-$965.7K
Capital Expenditures	$23.00K		$14.11M
Free Cash Flow	-$971.1K		-$15.08M
YoY Change			-40.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	adex	Earnings Per Share Redeemable Common Stock Diluted EarningsPerShareRedeemableCommonStockDiluted	0.14
CY2021	adex	Weighted Average Redeemable Common Basic And Diluted WeightedAverageRedeemableCommonBasicAndDiluted	26492055
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.08
CY2022	adex	Allocation Of Net Loss Including Shares Of Common Stock Subject To Possible Redemption AllocationOfNetLossIncludingSharesOfCommonStockSubjectToPossibleRedemption	972392
CY2021	adex	Allocation Of Net Loss Including Shares Of Common Stock Subject To Possible Redemption AllocationOfNetLossIncludingSharesOfCommonStockSubjectToPossibleRedemption	-541088
CY2022	adex	Weighted Average Redeemable Common Basic And Diluted WeightedAverageRedeemableCommonBasicAndDiluted	27393431
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Entity File Number EntityFileNumber	001-39872
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3477678
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1345 Avenue of the Americas
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10105
CY2022	dei	City Area Code CityAreaCode	646
CY2022	dei	Local Phone Number LocalPhoneNumber	291-6930
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q4	us-gaap	Cash Cash	992187
CY2021Q4	us-gaap	Cash Cash	462274
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	77774
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	33rd Floor
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4832848
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	265282
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	adex	Number Of Maximum Extension Month For Initial Business Combination NumberOfMaximumExtensionMonthForInitialBusinessCombination	P6M
CY2022	adex	Number Of Trading Days NumberOfTradingDays	P20D
CY2022	adex	Number Of Consecutive Trading Days NumberOfConsecutiveTradingDays	P30D
CY2022	adex	Warrants Redemption Covenant Threshold Trading Days WarrantsRedemptionCovenantThresholdTradingDays	P20Y
CY2022	adex	Warrants Redemption Covenant Threshold Consecutive Trading Days WarrantsRedemptionCovenantThresholdConsecutiveTradingDays	P30Y
CY2022	adex	Number Of Business Days Before Sending Notice Of Redemption Period NumberOfBusinessDaysBeforeSendingNoticeOfRedemptionPeriod	P3Y
CY2022	adex	Number Of Trading Days Prior On Consummates Business Combination NumberOfTradingDaysPriorOnConsummatesBusinessCombination	P10Y
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y5M4D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10M28D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y4M24D
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022Q2	dei	Entity Public Float EntityPublicFloat	271600000
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9367422
CY2022	dei	Auditor Name AuditorName	Marcum LLP
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	1093204
CY2022Q4	us-gaap	Assets Current AssetsCurrent	2163165
CY2021Q4	us-gaap	Assets Current AssetsCurrent	727556
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	14384
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	25041388
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	276115444
CY2022Q4	us-gaap	Assets Assets	27204553
CY2021Q4	us-gaap	Assets Assets	276857384
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4807419
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3153755
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	138986
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	18986
CY2022Q4	adex	Common Stock To Be Redeemed CommonStockToBeRedeemed	1093204
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	795203
CY2022Q4	adex	Working Capital Loan Related Party WorkingCapitalLoanRelatedParty	300000
CY2021Q4	adex	Working Capital Loan Related Party WorkingCapitalLoanRelatedParty	150000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7134812
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3322741
CY2022Q4	adex	Warrant Liability WarrantLiability	459236
CY2021Q4	adex	Warrant Liability WarrantLiability	5044441
CY2022Q4	adex	Deferred Underwriting Discount Noncurrent DeferredUnderwritingDiscountNoncurrent	6762000
CY2021Q4	adex	Deferred Underwriting Discount Noncurrent DeferredUnderwritingDiscountNoncurrent	9660000
CY2022Q4	us-gaap	Liabilities Liabilities	14356048
CY2021Q4	us-gaap	Liabilities Liabilities	18027182
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2467422
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	27600000
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.24
CY2021Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.00
CY2022Q4	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	25273823
CY2021Q4	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	276000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6900000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6900000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6900000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6900000
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2467422
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	27600000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	690
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	690
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1103029
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13529037
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17170488
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-12425318
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-17169798
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27204553
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	276857384
CY2022	us-gaap	Operating Expenses OperatingExpenses	2941239
CY2021	us-gaap	Operating Expenses OperatingExpenses	3704239
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2941239
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-3704239
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4585205
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-956035
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	3984085
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	115444
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8569290
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1071479
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5628051
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2632760
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	795203
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4832848
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2632760
CY2022	adex	Weighted Average Redeemable Common Basic And Diluted WeightedAverageRedeemableCommonBasicAndDiluted	27393431
CY2022	adex	Weighted Average Redeemable Common Basic And Diluted WeightedAverageRedeemableCommonBasicAndDiluted	27393431
CY2021	adex	Weighted Average Redeemable Common Basic And Diluted WeightedAverageRedeemableCommonBasicAndDiluted	26492055
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.14
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.14
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.08
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6900000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6900000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6853151
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6853151
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	24474
CY2021	adex	Adjustments To Additional Paid In Capital Offering Costs Allocated To Warrants AdjustmentsToAdditionalPaidInCapitalOfferingCostsAllocatedToWarrants	981103
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	31621284
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2632760
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-17169798
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	2986368
CY2022	adex	Adjustments To Additional Paid In Capital Reduction Of Deferred Underwriter Fees AdjustmentsToAdditionalPaidInCapitalReductionOfDeferredUnderwriterFees	2898000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-12425318
CY2022	us-gaap	Profit Loss ProfitLoss	4832848
CY2021	us-gaap	Profit Loss ProfitLoss	-2632760
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4585205
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-956035
CY2022	adex	Interest Earned On Cash And Marketable Securities Held In Trust Account InterestEarnedOnCashAndMarketableSecuritiesHeldInTrustAccount	3984085
CY2021	adex	Interest Earned On Cash And Marketable Securities Held In Trust Account InterestEarnedOnCashAndMarketableSecuritiesHeldInTrustAccount	115444
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-201892
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	279666
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	795203
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1653664
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3311387
CY2022	adex	Cash Held In Trust For Redeemed Shares CashHeldInTrustForRedeemedShares	1093204
CY2022	adex	Common Stocks To Be Redeemed CommonStocksToBeRedeemed	1093204
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	120000
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	214
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-965683
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-672304
CY2021	adex	Investment Held In Trust Account InvestmentHeldInTrustAccount	276000000
CY2022	adex	Cash Withdrawn For Redemptions Net CashWithdrawnForRedemptionsNet	253712545
CY2022	adex	Cash Withdrawn From Trust Account To Pay Franchise Tax And Income Taxes CashWithdrawnFromTrustAccountToPayFranchiseTaxAndIncomeTaxes	1345596
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	255058141
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-276000000
CY2021	adex	Proceeds From Initial Public Offering Net Of Underwriters Fees ProceedsFromInitialPublicOfferingNetOfUnderwritersFees	270480000
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	7270000
CY2021	adex	Payments Of Offering Costs PaymentsOfOfferingCosts	651036
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	150000
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	150000
CY2022	adex	Redemption Of Common Stock Net RedemptionOfCommonStockNet	253712545
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	150000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-253562545
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	277098964
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	529913
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	426660
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	462274
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	35614
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	992187
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	462274
CY2022	adex	Deferred Underwriting Commissions Charged To Additional Paid In Capital DeferredUnderwritingCommissionsChargedToAdditionalPaidInCapital	-2898000
CY2021	adex	Deferred Underwriting Commissions Charged To Additional Paid In Capital DeferredUnderwritingCommissionsChargedToAdditionalPaidInCapital	9660000
CY2021	adex	Initial Value Of Common Stock Subject To Possible Redemption InitialValueOfCommonStockSubjectToPossibleRedemption	276000000
CY2022	adex	Noncash Remeasurement Of Carrying Value To Redemption Value NoncashRemeasurementOfCarryingValueToRedemptionValue	2986368
CY2021	adex	Deferred Offering Costs Paid By Sponsor Loan DeferredOfferingCostsPaidBySponsorLoan	18773
CY2021	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement	6000476
CY2022	adex	Reduction Of Deferred Underwriting Fee Payable ReductionOfDeferredUnderwritingFeePayable	2898000
CY2021Q1	adex	Sale Of Private Placement Warrants SaleOfPrivatePlacementWarrants	6550000
CY2021Q1	adex	Cost Of Per Private Placement Warrant CostOfPerPrivatePlacementWarrant	1.00
CY2021Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6550000
CY2021Q1	adex	Period Of Underwriters Option To Purchase Units PeriodOfUnderwritersOptionToPurchaseUnits	P45D
CY2021Q1	adex	Deferred Underwriting Fees DeferredUnderwritingFees	720000
CY2021Q1	adex	Sale Of Private Placement Warrants SaleOfPrivatePlacementWarrants	720000
CY2021Q1	adex	Cost Of Per Private Placement Warrant CostOfPerPrivatePlacementWarrant	1.00
CY2021Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	720000
CY2021Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	13800000
CY2021Q1	adex	Underwriting Discount UnderwritingDiscount	4800000
CY2021Q1	adex	Deferred Underwriting Discounts And Commissions DeferredUnderwritingDiscountsAndCommissions	8400000
CY2021Q1	adex	Other Offering Costs OtherOfferingCosts	600000
CY2021Q1	us-gaap	Assets Held In Trust AssetsHeldInTrust	276000000
CY2022Q4	adex	Anticipated Stock Redemption Price Per Share AnticipatedStockRedemptionPricePerShare	10.00
CY2022Q4	adex	Business Combination Minimum Threshold Limit Of Net Intangible Assets Required BusinessCombinationMinimumThresholdLimitOfNetIntangibleAssetsRequired	5000001
CY2022	adex	Restriction On Public Share Redemption In Case Of Stockholder Approval Of Business Combination RestrictionOnPublicShareRedemptionInCaseOfStockholderApprovalOfBusinessCombination	0.15
CY2022	adex	Business Combination Incomplete Percentage Of Stock Redemption BusinessCombinationIncompletePercentageOfStockRedemption	1
CY2022	adex	Business Combination Completion Date Of Acquisition BusinessCombinationCompletionDateOfAcquisition	2023-07-14
CY2022Q4	adex	Temporary Equity Shares Redeemed TemporaryEquitySharesRedeemed	25132578
CY2022Q4	adex	Temporary Equity Redemption Value TemporaryEquityRedemptionValue	253600000
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.09
CY2022	adex	Price Per Share Reduction To Amount Held In Trust PricePerShareReductionToAmountHeldInTrust	10.00
CY2022Q4	adex	Operating Bank Account Balance OperatingBankAccountBalance	1000000.0
CY2022Q4	adex	Working Capital Deficit WorkingCapitalDeficit	5200000
CY2022Q4	adex	Federal Income Tax And Prepaid Franchise Tax Payable FederalIncomeTaxAndPrepaidFranchiseTaxPayable	700000
CY2022Q4	adex	Operating Bank Account Balance OperatingBankAccountBalance	1000000.0
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#212529;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of <span style="color:#000000;">consolidated</span> financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the<span style="color:#000000;"> consolidated</span> financial statements and the reported amounts of revenues and expenses during the reporting<span style="color:#000000;"> periods</span>.</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the<span style="color:#000000;"> consolidated</span> financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2021	adex	Allocation Of Net Loss Including Shares Of Common Stock Subject To Possible Redemption AllocationOfNetLossIncludingSharesOfCommonStockSubjectToPossibleRedemption	-541088
CY2022	adex	Weighted Average Redeemable Common Diluted WeightedAverageRedeemableCommonDiluted	27393431
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#212529;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At December 31, <span style="color:#000000;">2022 and December 31,</span> 2021, the Company has not experienced losses on this account, and management believes <span style="color:#000000;">that</span> the Company is not exposed to significant risks on such account.</p>
CY2022	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000
CY2022Q4	adex	Number Of Additional Extension Month For Initial Business Combination NumberOfAdditionalExtensionMonthForInitialBusinessCombination	P1M
CY2022Q4	adex	Number Of Business Days NumberOfBusinessDays	10
CY2022Q4	adex	Temporary Equity Shares Redeemed TemporaryEquitySharesRedeemed	25132578
CY2022Q4	adex	Temporary Equity Redemption Value TemporaryEquityRedemptionValue	253600000
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.09
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2467422
CY2022	adex	Allocation Of Net Loss Including Shares Of Redeemable Common Stock Subject To Possible Redemption AllocationOfNetLossIncludingSharesOfRedeemableCommonStockSubjectToPossibleRedemption	3860456
CY2022	adex	Allocation Of Net Loss Including Shares Of Redeemable Common Stock Subject To Possible Redemption AllocationOfNetLossIncludingSharesOfRedeemableCommonStockSubjectToPossibleRedemption	3860456
CY2022	adex	Allocation Of Net Loss Including Shares Of Common Stock Subject To Possible Redemption AllocationOfNetLossIncludingSharesOfCommonStockSubjectToPossibleRedemption	972392
CY2021	adex	Allocation Of Net Loss Including Shares Of Redeemable Common Stock Subject To Possible Redemption AllocationOfNetLossIncludingSharesOfRedeemableCommonStockSubjectToPossibleRedemption	-2091672
CY2021	adex	Allocation Of Net Loss Including Shares Of Redeemable Common Stock Subject To Possible Redemption AllocationOfNetLossIncludingSharesOfRedeemableCommonStockSubjectToPossibleRedemption	-2091672
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6900000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6900000
CY2021	adex	Weighted Average Redeemable Common Diluted WeightedAverageRedeemableCommonDiluted	26492055
CY2021	adex	Weighted Average Redeemable Common Basic And Diluted WeightedAverageRedeemableCommonBasicAndDiluted	26492055
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6853151
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6853151
CY2022	adex	Earnings Per Share Redeemable Common Stock Basic EarningsPerShareRedeemableCommonStockBasic	0.14
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2021	adex	Earnings Per Share Redeemable Common Stock Diluted EarningsPerShareRedeemableCommonStockDiluted	-0.08
CY2021	adex	Earnings Per Share Redeemable Common Stock Basic EarningsPerShareRedeemableCommonStockBasic	-0.08
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#212529;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Derivative Financial Instruments</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-40, “Derivatives and Hedging – Contracts in Entity’s Own Stock (“ASC 815-40”).” The classification </p> <p style="margin-top:10pt;margin-bottom:0pt;color:#212529;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#212529;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December 31,<span style="color:#000000;"> 2022 and December 31,</span> 2021, the Company has evaluated both the <span style="color:#000000;">Public Warrants (as defined below) and Private Placement Warrants </span>under ASC 480 and ASC 815-40. <span style="Background-color:#FFFFFF;color:#000000;">Such guidance provides that because the Private Placement Warrants do not meet the criteria for equity treatment thereunder, each Private Placement Warrant must be recorded as a liability. Accordingly, the Company classified each </span><span style="color:#000000;">Private Placement Warrant </span><span style="Background-color:#FFFFFF;color:#000000;">as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s consolidated statement</span><span style="color:#000000;">s</span><span style="Background-color:#FFFFFF;color:#000000;"> of operations. </span><span style="color:#000000;">On the date of the IPO, the Company’s </span><span style="Background-color:#FFFFFF;color:#000000;">Private Placement Warrants met the </span><span style="color:#000000;">criteria </span><span style="Background-color:#FFFFFF;color:#000000;">for equity accounting treatment. On December 23, 2021, the Private Placement Warrants were modified such that the Private Placement Warrants no longer meet the criteria for equity treatment. As such, the Private Placement Warrants were treated as derivative liability instruments from the date of the modification.</span></p>
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	12.00
CY2022	adex	Minimum Share Holding Period Upon Closing Of Business Combination MinimumShareHoldingPeriodUponClosingOfBusinessCombination	P150D
CY2021Q2	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	400000
CY2021Q2	adex	Related Party Transaction Units Profit Interest Percentage RelatedPartyTransactionUnitsProfitInterestPercentage	0.005
CY2021Q2	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	The cash payment will be due and payable upon the closing of the Merger.
CY2022Q3	adex	Us Federal Excise Tax On Repurchase Of Stock Rate USFederalExciseTaxOnRepurchaseOfStockRate	0.01
CY2022Q3	adex	Us Federal Excise Tax On Repurchase Of Stock Rate USFederalExciseTaxOnRepurchaseOfStockRate	0.01
CY2022Q4	adex	Temporary Equity Shares Redeemed TemporaryEquitySharesRedeemed	25132578
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2467422
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.24
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	276000000
CY2022	adex	Proceeds Allocated To Public Warrants ProceedsAllocatedToPublicWarrants	16771351
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	14849933
CY2021	adex	Remeasurement Of Carrying Value To Redemption Value RemeasurementOfCarryingValueToRedemptionValue	31621284
CY2021Q4	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	276000000
CY2022	adex	Remeasurement Of Carrying Value To Redemption Value RemeasurementOfCarryingValueToRedemptionValue	2986368
CY2022	adex	Redemption Of Common Stock RedemptionOfCommonStock	253712545
CY2022Q4	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	25273823
CY2021Q1	adex	Sale Of Private Placement Warrants SaleOfPrivatePlacementWarrants	6550000
CY2021Q1	adex	Cost Of Per Private Placement Warrant CostOfPerPrivatePlacementWarrant	1.00
CY2021Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6550000
CY2021Q1	adex	Sale Of Private Placement Warrants SaleOfPrivatePlacementWarrants	720000
CY2021Q1	adex	Cost Of Per Private Placement Warrant CostOfPerPrivatePlacementWarrant	1.00
CY2021Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	720000
CY2022	adex	Share Holding Period Upon Closing Of Business Combination ShareHoldingPeriodUponClosingOfBusinessCombination	P1Y
CY2022	adex	Related Party Transaction Vesting Description RelatedPartyTransactionVestingDescription	The units vested as to one-fourth on April 16, 2022 and have vested and will continue to vest 1/36th on the 17th day of each month thereafter, subject to such entity’s continued service through such vesting dates, provided, however, that any unvested units shall fully vest upon the consummation of a merger with a special purpose acquisition company, qualified initial public offering, or other change of control transaction.
CY2022	adex	Proceeds From Related Parties ProceedsFromRelatedParties	139000
CY2021	adex	Proceeds From Related Parties ProceedsFromRelatedParties	19000
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.00
CY2022Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	25041388
CY2022Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	25041388
CY2021Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	276115444
CY2021Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	4535
CY2021Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	276119979
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.1320
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0121
CY2021Q4	us-gaap	Share Price SharePrice	9.88
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.50
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.083
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.1170
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0474
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0120
CY2022Q4	us-gaap	Share Price SharePrice	10.11
CY2021Q4	us-gaap	Share Price SharePrice	9.90
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.50
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.50
CY2022	adex	Registration Rights Agreement Term RegistrationRightsAgreementTerm	The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement signed on January 11, 2021, requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
CY2022	adex	Registration Rights Agreement Date RegistrationRightsAgreementDate	2021-01-11
CY2021Q3	adex	Contingent Fee Upon Consummation Of Merger ContingentFeeUponConsummationOfMerger	500000
CY2021Q3	adex	Contingent Fee Upon Consummation Of Merger ContingentFeeUponConsummationOfMerger	250000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	adex	Common Stock Shares Issued Including Shares Subject To Possible Redemption CommonStockSharesIssuedIncludingSharesSubjectToPossibleRedemption	9367422
CY2021Q4	adex	Common Stock Shares Issued Including Shares Subject To Possible Redemption CommonStockSharesIssuedIncludingSharesSubjectToPossibleRedemption	9367422
CY2022Q4	adex	Common Stock Shares Outstanding Including Shares Subject To Possible Redemption CommonStockSharesOutstandingIncludingSharesSubjectToPossibleRedemption	34500000
CY2021Q4	adex	Common Stock Shares Outstanding Including Shares Subject To Possible Redemption CommonStockSharesOutstandingIncludingSharesSubjectToPossibleRedemption	34500000
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2467422
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	27600000
CY2022	adex	Warrants Exercisable Period After Completion Of Business Combination WarrantsExercisablePeriodAfterCompletionOfBusinessCombination	P30D
CY2022	adex	Warrant Expiration Period After Completion Of Business Combination Earlier Upon Redemption Liquidation WarrantExpirationPeriodAfterCompletionOfBusinessCombinationEarlierUponRedemptionLiquidation	P5Y
CY2022Q4	adex	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	0
CY2022Q4	adex	Class Of Warrant Or Right Redemption Price ClassOfWarrantOrRightRedemptionPrice	0.01
CY2022	adex	Minimum Period Of Prior Written Notice Of Redemption Of Warrants MinimumPeriodOfPriorWrittenNoticeOfRedemptionOfWarrants	P30D
CY2022Q4	adex	Minimum Price Per Share Required For Redemption Of Warrants MinimumPricePerShareRequiredForRedemptionOfWarrants	18.00
CY2022Q4	adex	Redemption Triggering Price Of Warrants RedemptionTriggeringPriceOfWarrants	18.00
CY2022Q4	adex	Class Of Warrants Redemption Exercise Price Per Share ClassOfWarrantsRedemptionExercisePricePerShare	11.50
CY2022Q4	adex	Maximum Effective Issue Price To Closing Of Business Combination MaximumEffectiveIssuePriceToClosingOfBusinessCombination	9.20
CY2022Q4	adex	Minimum Percentage Of Equity Proceeds From Issuances MinimumPercentageOfEquityProceedsFromIssuances	0.60
CY2022Q4	adex	Percentage Of Exercise Price Of Warrants Adjusted Equal To Higher Of Market Value And Newly Issued Price PercentageOfExercisePriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndNewlyIssuedPrice	1.15
CY2022Q4	adex	Redemption Triggering Price Of Warrants RedemptionTriggeringPriceOfWarrants	18.00
CY2022Q4	adex	Percentage Of Warrant Redemption Trigger Price Adjusted Equal To Higher Of Market Value And Newly Issued Price PercentageOfWarrantRedemptionTriggerPriceAdjustedEqualToHigherOfMarketValueAndNewlyIssuedPrice	1.80
CY2022Q4	adex	Deferred Tax Assets Organizational Costs Startup Expenses DeferredTaxAssetsOrganizationalCostsStartupExpenses	321981
CY2021Q4	adex	Deferred Tax Assets Organizational Costs Startup Expenses DeferredTaxAssetsOrganizationalCostsStartupExpenses	152688
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	17851
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	321981
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	170539
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	321981
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	170539
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	795203
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-151332
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-170539
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	151332
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	170539
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	795203
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	151332
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	170539
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000
CY2022	adex	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants	-0.171
CY2021	adex	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants	0.076
CY2022	adex	Effective Income Tax Rate Reconciliation Acquisition Related Expenses EffectiveIncomeTaxRateReconciliationAcquisitionRelatedExpenses	0.075
CY2021	adex	Effective Income Tax Rate Reconciliation Acquisition Related Expenses EffectiveIncomeTaxRateReconciliationAcquisitionRelatedExpenses	-0.221
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.027
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.065
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.141

Files In Submission

Name	View Source	Status
0001564590-23-004568-index-headers.html	Edgar Link	pending
0001564590-23-004568-index.html	Edgar Link	pending
0001564590-23-004568.txt	Edgar Link	pending
0001564590-23-004568-xbrl.zip	Edgar Link	pending
adex-10k_20221231.htm	Edgar Link	pending
adex-20221231.xsd	Edgar Link	pending
adex-ex211_6.htm	Edgar Link	pending
adex-ex311_10.htm	Edgar Link	pending
adex-ex312_8.htm	Edgar Link	pending
adex-ex31_109.htm	Edgar Link	pending
adex-ex321_7.htm	Edgar Link	pending
adex-ex322_9.htm	Edgar Link	pending
adex-ex46_108.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
adex-20221231_pre.xml	Edgar Link	unprocessable
adex-20221231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
adex-20221231_lab.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
adex-20221231_cal.xml	Edgar Link	unprocessable
adex-10k_20221231_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GRDI
Stock $grdi

2023 Q1 Form 10-K Financial Statement

#000156459023004568 Filed on March 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRDI Stock $grdi

2023 Q1 Form 10-K Financial Statement

#000156459023004568 Filed on March 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRDI
Stock $grdi